Orthofix Medical Inc (Orthofix) offers a wide range of products including biologics, advanced spinal hardware, bone growth therapies, specialized orthopedic solutions, and an advanced surgical navigation system.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Orthofix's primary research and development facilities are strategically located in Lewisville, Texas; Carlsbad, California; Toronto, Canada; and Verona, Italy. The company operates a dedicated R&D organization focused on advancing its portfolio of spinal implants, biologics, orthopedic devices, and machine vision image guidance innovations. Orthofix employs an integrated team approach for product development, involving collaboration between surgeons, engineers, machinists, and regulatory personnel. The company also partners with leading hospital research institutions, surgeons, consultants, and non-profit organizations such as MTF Biologics. The product development process at Orthofix includes seeking suggestions from the scientific and medical communities, occasionally resulting in assignment or license agreements with physicians and third parties. For spine and orthopedics products, design teams work with design surgeons to create prototypes, which are tested in-house. Prototypes are refined based on testing outcomes, enabling rapid iterations of the design process. Orthofix's software engineers and product managers are also integrating spinal implants and biologics with the 7D FLASH Navigation System. This integration aims to enhance a wide range of procedures, including complex and minimally invasive spine surgeries, and explore applications in both adult and pediatric orthopedics. For biologics, Orthofix is focused on developing new formulations and process improvements to enhance bone-forming potential. The Biologics R&D team is experienced in biomaterial sciences and advancing next-generation technologies. In FY2024, the company spent US$73.6 million on its R&D activities, which as a percentage of revenue stood at 9.2%.